These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19569971)

  • 1. Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes.
    Sawe FK; McIntyre JA
    Clin Infect Dis; 2009 Aug; 49(3):463-5. PubMed ID: 19569971
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.
    Schuelter-Trevisol F; Trevisol DJ; Fuchs SC
    AIDS; 2009 Apr; 23(7):871-2; author reply 872-3. PubMed ID: 19363333
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell phones: tightening the communication gap in resource-limited antiretroviral programmes?
    Lester RT; Gelmon L; Plummer FA
    AIDS; 2006 Nov; 20(17):2242-4. PubMed ID: 17086071
    [No Abstract]   [Full Text] [Related]  

  • 6. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?
    Lawn SD; Wood R
    J Infect Dis; 2006 Nov; 194(10):1467-8; author reply 1468. PubMed ID: 17054078
    [No Abstract]   [Full Text] [Related]  

  • 8. Logistics and models of implementing large-scale HIV treatment, care and support in Africa.
    Darkoh-Ampem E; Sargent J; Butler J
    J HIV Ther; 2006 Mar; 11(1):16-20. PubMed ID: 16706251
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 10. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET; Oelrichs RB
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract]   [Full Text] [Related]  

  • 11. Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition.
    Grimsrud A; Ford N; Myer L
    Trop Med Int Health; 2011 Mar; 16(3):390-1; author reply 392. PubMed ID: 21143352
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV/AIDS: monitoring, the key to antiretroviral treatment efficacity].
    Rev Infirm; 2003 Feb; (88):8. PubMed ID: 12696347
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral roll-out: the problem of second-line therapy.
    Boyd M; Emery S; Cooper DA
    Lancet; 2009 Jul; 374(9685):185-6. PubMed ID: 19616706
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi.
    Muula AS
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):627; author reply 627-8. PubMed ID: 17207825
    [No Abstract]   [Full Text] [Related]  

  • 15. South Africa will not pay for antiretroviral therapy.
    Sidley P
    BMJ; 2001 Jun; 322(7300):1441. PubMed ID: 11408289
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi.
    Beadles WI; Jahn A; Weigel R; Clutterbuck D
    Trop Doct; 2009 Apr; 39(2):78-80. PubMed ID: 19299286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAART for the HIV-infected employees of large companies in Africa.
    Van der Borght S; Rinke de Wit TF; Janssens V; Schim van der Loeff MF; Rijckborst H; Lange JM
    Lancet; 2006 Aug; 368(9534):547-50. PubMed ID: 16890844
    [No Abstract]   [Full Text] [Related]  

  • 18. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
    Hetherington S
    Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings.
    Cheng B; Landay A; Miller V
    Curr Opin HIV AIDS; 2008 Jul; 3(4):495-503. PubMed ID: 19373011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.